http://rdf.ncbi.nlm.nih.gov/pubchem/reference/18051772

Outgoing Links

Predicate Object
contentType Comparative Study|Journal Article|Meta-Analysis|Systematic Review|Validation Study
endingPage 102
issn 1875-8908
1387-2877
issueIdentifier 1
pageRange 89-102
publicationName Journal of Alzheimer's disease : JAD
startingPage 89
bibliographicCitation Zhou B, Teramukai S, Yoshimura K, Fukushima M. Validity of cerebrospinal fluid biomarkers as endpoints in early-phase clinical trials for Alzheimer's disease. J Alzheimers Dis. 2009;18(1):89–102. doi: 10.3233/jad-2009-1124. PMID: 19542628.
creator http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_883bddc001fd8fd8e94ef0592ed75fc1
http://rdf.ncbi.nlm.nih.gov/pubchem/author/ORCID_0000-0003-2184-0597
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_225bd61fa24ab7690335443af37c1320
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_e361b5c091e7e01b4df6c9c33a811644
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_4948797f2277c4d720b93220fa0175b9
date 2009-07-29-04:00^^<http://www.w3.org/2001/XMLSchema#date>
identifier https://pubmed.ncbi.nlm.nih.gov/19542628
https://doi.org/10.3233/jad-2009-1124
isPartOf http://rdf.ncbi.nlm.nih.gov/pubchem/journal/21942
https://portal.issn.org/resource/ISSN/1387-2877
https://portal.issn.org/resource/ISSN/1875-8908
language English
source https://pubmed.ncbi.nlm.nih.gov/
https://www.crossref.org/
title Validity of Cerebrospinal Fluid Biomarkers as Endpoints in Early-Phase Clinical Trials for Alzheimer's Disease
discusses http://id.nlm.nih.gov/mesh/M0025678
http://id.nlm.nih.gov/mesh/M0023752
hasPrimarySubjectTerm http://id.nlm.nih.gov/mesh/D002986Q000592
http://id.nlm.nih.gov/mesh/D023381Q000592
http://id.nlm.nih.gov/mesh/D000544Q000134
hasSubjectTerm http://id.nlm.nih.gov/mesh/D006801
http://id.nlm.nih.gov/mesh/D015415Q000134
http://id.nlm.nih.gov/mesh/D000544Q000175
http://id.nlm.nih.gov/mesh/D013997
http://id.nlm.nih.gov/mesh/D016875Q000134

Total number of triples: 34.